Role of oxygen free radicals in cocaine-induced vascular disruption in mice

Teratology. 1994 Mar;49(3):192-201. doi: 10.1002/tera.1420490315.

Abstract

To test the hypothesis that cocaine-induced embryonic vascular disruption is mediated by oxygen free radicals, the antioxidants 2-oxothiazolidine-4-carboxylate (OTC) and alpha-phenyl-N-t-butyl nitrone (PBN) were employed. When cocaine (78 mg/kg) was administered on day 8 of gestation to ICR mice and embryos evaluated on day 10 (in vivo), 62.3% of cocaine-treated embryos showed increased vasodilation compared to 4.9% for controls, and 33.1% of the cocaine-exposed embryos showed marked hemorrhage compared to 3.3% for controls. In addition, cocaine increased the incidence of neural defects, in the form of open neural tube, hypoplastic prosencephalon, and microcephaly. Administration of OTC (0.25 and 0.5 mmol/kg) or PBN (300 mg/kg) prior to cocaine significantly reduced cocaine-induced vasodilation and hemorrhage, while not preventing neural defects. When cocaine (78 mg/kg) was administered in vivo on day 8 of gestation and embryos were dissected 15 min later and subsequently cultured for 48 hr in the absence of cocaine (in vivo-in vitro), marked vascular disruption was observed: normal yolk circulation/heartbeat was decreased to 26.6%, while edema/blisters and vasodilation/hemorrhage were increased to 45.6% and 59.6%, respectively. Administration of PBN (300 mg/kg) prior to cocaine completely prevented cocaine-induced vascular disruption. When cocaine was administered in vivo and PBN (300 micrograms/ml) was incubated with cultured embryos in vitro, the antioxidant only partially prevented cocaine-induced cardiovascular defects in this model. Neural defects produced by cocaine were not significantly affected by PBN, administered either in vivo or in vitro. Cocaine (78 mg/kg) administered in vivo stimulated lipid peroxidation maximally after 3 hr in both day 8 and day 9 embryos. When cocaine was incubated in vitro during embryo culture at 33 micrograms/ml, a concentration that produces nonspecific inhibition of growth and development, embryonic lipid peroxidation on day 9 was not affected. Finally, when PBN (300 mg/kg) was administered prior to cocaine (78 mg/kg) on day 8 of gestation, stimulation of lipid peroxidation by cocaine was prevented. These results suggest that cocaine-induced vascular disruption in early development is mediated by maternal production of oxygen free radicals.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Abnormalities, Drug-Induced / embryology*
  • Abnormalities, Drug-Induced / metabolism
  • Abnormalities, Drug-Induced / prevention & control
  • Animals
  • Antioxidants / pharmacology*
  • Antioxidants / therapeutic use
  • Aorta / abnormalities
  • Aorta / embryology
  • Blood Vessels / abnormalities*
  • Blood Vessels / embryology
  • Cocaine / toxicity*
  • Cyclic N-Oxides
  • Female
  • Fetal Diseases / chemically induced*
  • Fetal Diseases / metabolism
  • Fetal Heart / drug effects
  • Gestational Age
  • Hemorrhage / chemically induced
  • Hemorrhage / embryology
  • Lipid Peroxidation / drug effects
  • Maternal-Fetal Exchange
  • Mice / embryology*
  • Mice, Inbred ICR
  • Nervous System / embryology
  • Nervous System Malformations
  • Neural Tube Defects / chemically induced
  • Nitrogen Oxides / pharmacology
  • Nitrogen Oxides / therapeutic use
  • Pregnancy
  • Pyrrolidonecarboxylic Acid
  • Reactive Oxygen Species / toxicity*
  • Thiazoles / pharmacology
  • Thiazoles / therapeutic use
  • Thiazolidines
  • Vasodilation / drug effects
  • Yolk Sac / blood supply

Substances

  • Antioxidants
  • Cyclic N-Oxides
  • Nitrogen Oxides
  • Reactive Oxygen Species
  • Thiazoles
  • Thiazolidines
  • phenyl-N-tert-butylnitrone
  • Cocaine
  • Pyrrolidonecarboxylic Acid
  • 2-oxothiazolidine-4-carboxylic acid